Dr. Jane Reznick completed her PhD in Sydney, Australia, studying the impact of circadian rhythms (i.e. physical, mental, and behavioral changes that follow a 24-hour cycle) on metabolism. She moved to the Max Delbrück Centre Berlin to investigate molecular adaptations in the naked mole-rat. Whilst there, Jane also discovered a novel protein important for insulin sensitivity and is now developing a drug for the treatment of Diabetes. In July 2020 Jane started her own group at CECAD Cologne where she continues to utilize naked mole-rats as a model to understand ageing and metabolism.
Jane Reznick is a speaker at Symposium Düsseldorf